Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/CPH stock hub

TSX/CPH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/CPHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

501.2M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/CPH

In the news

Latest news · TSX/CPH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.9

P25 11P50 15.6P75 25.4

Trailing P/E11.9

P25 7.4P50 15.6P75 34.3

ROE25.9

P25 -121.5P50 -40.9P75 0.5

ROIC16

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/CPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	5
Employees Change	-1%
Employees Change Percent	-16.67
Enterprise value	CAD 492.9M
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA17253X1050
Last refreshed	2026-05-10
Market cap	CAD 501.2M
Price	CAD 19.74
Price currency	CAD
Rev Per Employee	14,220,184.2x
Sector	Healthcare
Sic	2834
Symbol	tsx/CPH
Website	https://www.cipherpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.6%
EV Earnings	11.44x
EV/EBIT	17.55x
EV/EBITDA	12.92x
EV/FCF	11.77x
EV/Sales	6.93x
FCF yield	8.35%
Forward P/E	16.92x
P/B ratio	2.71x
P/E ratio	11.86x
P/S ratio	7.05x
PE Ratio10 Y	11.09x
PE Ratio3 Y	12.04x
PE Ratio5 Y	9.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.49%
EBITDA Margin	53.1%
FCF margin	58.9%
Gross margin	81.63%
Gross Profit	CAD 58M
Gross Profit Growth	46.25%
Gross Profit Growth Q	12.66%
Gross Profit Growth3 Y	36.64%
Gross Profit Growth5 Y	18.19%
Net Income	CAD 43.1M
Net Income Growth	233.85%
Net Income Growth Q	134.87%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	4.42%
Net Income Growth5 Y	56.89%
Pretax Margin	39.71%
Profit Margin	60.6%
Profit Per Employee	CAD 8.6M
Profitable Years	9
ROA	7.95
Roa5y	9.33
ROCE	15.13
ROE	25.94
Roe5y	27.63
ROIC	16.03
Roic5y	26.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.03%
Cagr15y	23.33%
Cagr1y	37.69%
Cagr20y	7.38%
Cagr3y	81.87%
Cagr5y	68.36%
EPS Growth	227.7
EPS Growth Q	140
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	4.17
EPS Growth5 Y	58.21
FCF Growth Q	7.18%
FCF Growth3 Y	30.96%
FCF Growth5 Y	23.09%
OCF Growth	40.77%
OCF Growth Q	7.16%
OCF Growth10 Y	15.85%
OCF Growth3 Y	30.74%
OCF Growth5 Y	23.09%
Revenue Growth	28.91x
Revenue Growth Q	4.04x
Revenue Growth Quarters	11x
Revenue Growth Years	3x
Revenue Growth3 Y	36.24x
Revenue Growth5 Y	19.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.32
Assets	CAD 214M
Cash	CAD 8.9M
Current Assets	CAD 34.9M
Current Liabilities	CAD 27.8M
Debt	CAD 597,428
Debt EBITDA	CAD 0.02
Debt Equity	CAD 0
Debt FCF	CAD 0.01
Equity	CAD 185.3M
Interest Coverage	26.96
Liabilities	CAD 28.7M
Long Term Assets	CAD 179.1M
Long Term Liabilities	CAD 817,119
Net Cash	CAD 8.4M
Net Cash By Market Cap	CAD 1.67
Net Debt EBITDA	CAD -0.22
Net Debt Equity	CAD -0.05
Net Debt FCF	CAD -0.2
Tangible Book Value	CAD 62.1M
Tangible Book Value Per Share	CAD 2.42
WACC	7.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.25
Inventory Turnover	1.36
Net Working Capital	CAD -1.4M
Quick ratio	0.79
Working Capital	CAD 7.2M
Working Capital Turnover	CAD 5.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	160.08%
1Y total return	37.66%
200-day SMA	15.4
3Y total return	501.83%
50-day SMA	17.36
50-day SMA vs 200-day SMA	50over200
5Y total return	1,252.06%
All Time High	20.56
All Time High Change	-3.99%
All Time High Date	2026-05-08
All Time Low	0.26
All Time Low Change	7,492.31%
All Time Low Date	2008-10-29
ATR	0.7
Beta	0.49
Beta1y	1.02
Beta2y	0.45
Ch YTD	31.08
High	20.56
High52	20.56
High52 Date	2026-05-08
High52ch	-3.99%
Low	18.72
Low52	11.87
Low52 Date	2025-05-22
Low52ch	66.3%
Ma50ch	13.7%
Price vs 200-day SMA	28.17%
RSI	67.82
RSI Monthly	71.31
RSI Weekly	70.26
Sharpe ratio	0.86x
Sortino ratio	1.77
Total Return	-0.65%
Tr YTD	31.08
Tr15y	2,222.35%
Tr1m	4.33%
Tr1w	10.53%
Tr3m	37.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 28.1M
Operating Income Growth	181.7
Operating Income Growth Q	126.2
Operating Income Growth3 Y	24.06
Operating Income Growth5 Y	11.06
Operating margin	39.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,923,970%
Net Borrowing	-55,103,051.4
Shares Insiders	3.55%
Shares Institutions	1.48%
Shares Out	25,391,322
Shares Qo Q	-1.61%
Shares Yo Y	0.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 39.4M
Average Volume	25,763.65x
Bv Per Share	7.22
CAPEX	CAD -37,688
Ch10y	160.1
Ch15y	2,222.4
Ch1m	4.33
Ch1w	10.53
Ch1y	37.66
Ch20y	315.6
Ch3m	37.08
Ch3y	501.8
Ch5y	1,252.1
Ch6m	46.44
Change	10.46%
Change From Open	3.95
Close	17.87
Days Gap	6.27
Depreciation Amortization	9,476,390.6
Dollar Volume	2,692,496.5
Earnings Date	2026-05-07
EBIT	CAD 28.1M
EBITDA	CAD 37.8M
EPS	CAD 1.66
F Score	5
FCF	CAD 41.9M
FCF EV Yield	8.5x
FCF Per Share	CAD 1.65
Financing CF	-63,469,754
Fiscal Year End	December
Founded	2,000
Goodwill	23,850,921.4
Graham Number	16.44
Graham Upside	-16.72
Income Tax	CAD -14.9M
Investing CF	-783,077
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	CAD 41.62
Lynch Upside	110.8
Ma150	15.55
Ma150ch	26.99%
Ma20	18.41
Ma20ch	7.21%
Net CF	-21,761,457
Open	18.99
P FCF Ratio	11.97
P OCF Ratio	11.96
Position In Range	55.43
Ppne	653,449.9
Price Date	2026-05-08
Price EBITDA	CAD 13.28
Ptbv Ratio	8.08
Relative Volume	5.42x
Revenue	71,100,921x
SBC By Revenue	3.53x
Share Based Comp	2,509,756
Tax By Revenue	-20.89x
Tr20y	315.58%
Tr6m	46.44%
Volume	136,398

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/CPH pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/CPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/CPH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.5%

Share of float held by funds and institutions

Insider ownership

+3.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

TSX/CPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.8

Neutral momentum band

Price vs 200-day MA

+28.2%

50/200-day relationship not available

Beta (5Y)

0.49

Less volatile than the market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/CPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/CPH stock rating?

tsx/CPH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/CPH analysis?

The full report lives at /stocks/tsx/CPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/CPH?

The latest report frames tsx/CPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/CPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.